KRAS and neoplasm: The multiplexed SCODA mutation detection assay was used to analyze extracted DNA from patient tumor tissue and pre-operative plasma samples for the presence of mutations in KRAS, PIK3CA, BRAF and EGFR as defined in our panel (Table 1).